Skip to main content
OpenTrials

Clinical trial condition

Hemophilia B

Explore clinical trials studying Hemophilia B. Study availability and eligibility vary by location and protocol.

205 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia B trial results

Completed

Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China

NCT02336178

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
  • Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View all 16 locations
View Trial Details
Completed

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

NCT00486278

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
View all 45 locations
View Trial Details
Completed

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

NCT00956345

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Novo Nordisk Investigational Site Cincinnati, Ohio, United States
  • Novo Nordisk Investigational Site Portland, Oregon, United States
  • Novo Nordisk Investigational Site Richmond, Virginia, United States
  • Novo Nordisk Investigational Site Copenhagen, Denmark
View all 19 locations
View Trial Details
Completed

Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State

NCT01562587

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Novo Nordisk Investigational Site Bremen, Germany
  • Novo Nordisk Investigational Site Frankfurt, Germany
  • Novo Nordisk Investigational Site Athens, Greece
  • Novo Nordisk Investigational Site Florence, Italy
View Trial Details

Related conditions